Custom Recombinant Protein Production Services Market

Custom Recombinant Protein Production Services
Market Outlook, and Opportunity Analysis 20182026
Custom recombinant protein production plays a major role in advanced healthcare and is the
most efficient technique used in life sciences. Recombinant proteins are used in a wide range of
applications in research, biotechnology, and medicine.
The global custom recombinant protein production services market size was valued at US$
2,600.21 million in 2017, and is expected to exhibit a CAGR of 11.2% over the forecast period
(2018 – 2026).
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/2737
Increasing funding in the field of life sciences is expected to propel growth of the custom
recombinant protein production services market
Recombinant protein is a manipulated form of protein, which is encoded by genes. It is used in
production of large quantities of protein, which is further used for manufacturing of therapeutic
commercial products. Increasing government initiatives and funding in the field of life sciences
is expected to boost growth of the market. For instance, Life Sciences Greenhouse of Central
Pennsylvania offers early stage funding of up to US$ 1-2 million in the form of convertible debt
or equity financing to viable life sciences companies, which have significant potential for
commercial growth.
Moreover, advancements in bioreactor systems have facilitated production of recombinant
protein within shorter time span, which in turn is expected to propel growth of the custom
recombinant protein production services market over the forecast period. For instance, according
to National Centre for Biotechnology Information (NCBI), in 2014, around 65.6% of clinical
scale manufacturers and 42% of commercial manufacturers adopted single-use bioreactors for
improvement in their bioprocessing.
Report includes chapters which deeply display the following deliverable about industry :
• Custom Recombinant Protein Production Services Market Research Objective and Assumption
• Custom Recombinant Protein Production Services Market Purview - Report Description,
Executive Summary, and Coherent Opportunity Map (COM)
• Custom Recombinant Protein Production Services Market Dynamics, Regulations, and Trends
Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New
system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Custom Recombinant Protein Production Services Market, By Regions
• Custom Recombinant Protein Production Services Market Competition by Manufacturers
including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales
Area and Product Type.
• Custom Recombinant Protein Production Services Market Manufacturers Profiles/Analysis
including Company Basic Information, Manufacturing Base and Its Competitors.
• Custom Recombinant Protein Production Services Market Manufacturing Cost Analysis
including Key Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Custom Recombinant Protein Production Services Market Forecast including Production,
Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Increasing research and development and product launches in North America is expected to
bolster the market growth
North America is expected to hold dominant position in the global custom recombinant protein
production services market, owing to increasing focus of regional players in research and
development and product launches. For instance, in 2014, Western Blot Service CRO, a division
of Altogen Lab, launched automated WES protein analysis and protein expression services,
providing a complete platform to conduct protein expression studies.
Moreover, the companies in the region are focused on adopting strategic acquisitions to expand
their geographic presence. For instance, in 2017, Eurofins Scientific acquired DiscoverX to
improve research productivity and accelerate the discovery and development of new drugs. The
acquisition is also expected to create a robust portfolio of kinase products and services in the
market.
Market Dynamics
Increasing demand for recombinant proteins for basic research has supported growth of the
custom recombinant protein production services market. Recombinant therapeutic proteins are
one of the fast-growing areas in molecular medicine. Various biopharmaceutical companies are
focusing on development of biologics and subsequently biosimilars. Moreover, increasing
expenditure in research has supported the market growth. The R&D spending of the U.S. is
around 2.7% of its Gross Domestic Products (GDP) with highest R&D investments observed in
the biotechnology segment in 2014, according to American Pharmaceutical Review.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/custom-recombinant-protein-productionservices-market-2737
Key Players
Major players operating in the custom recombinant protein production services market include,
GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery
Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc.,
ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus
Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, and Sino Biological
Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Custom recombinant protein production plays a major role in advanced healthcare and is the most efficient technique used in life sciences.

Download Report